TPT1P14

Across TCGA pan-cancer cohorts, TPT1P14 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of TPT1P14’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TPT1P14 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TPT1P14 is over-expressed in tumor, although a few such as LIHC and COAD show the opposite, repressed pattern.

KIRC, HNSC, and LUAD are the cancer types where TPT1P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TPT1P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.064	.001	5	view →
HNSC	Female	IV	+0.128	.031	4	view →
LUAD	All	All	+0.205	.005	3	view →
LIHC	Female	All	−0.040	.034	2	view →
STAD	All	IV	+0.373	.022	1	view →
COAD	Male	IV	−0.100	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

TPT1P14–KIRC

Open the KIRC breakdown →